Valuation
- Market cap
- 11,484,000
- Revenue TTM
- $0
- Net income TTM
- $-26,180,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 140,200
- Avg volume
- 149,750
- Day's range
- $1.26 – $1.41
- Shares out
- 8,087,000
- Stochastic %K
- 3%
- Beta
- 0.51
- Analysts
- Strong Buy
- Price target
- $21.75
Company profile
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of de...
Show more
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 833-304-0323
- Website
- https://www.quantumbiopharma.com
- Address
- 1 Adelaide Street East, Suite 801, Toronto, Canada
Latest news
No headlines yet.
Stocktwits
NetworkNewsWire
Nov 20, 6:24 PM
BioMedNewsBreaks –
$QNTM Gains Attention as ‘Men’s Fitness’ Highlights unbuzzd Trial Results https://ibn.fm/l7iW1
1 replies
FickleFin
Nov 20, 5:22 PM
$QNTM drop under a dollar then induce split to stay compliant... just like
$GNS Roger. 📉☠️
0 replies
FickleFin
Nov 20, 3:13 PM
$QNTM selling shares, looking like breach of contract lawsuit from 2023 is coming to an end. Court seems to favor the plaintiff not Quantum. QNTM deserves to rot. RS and Name Change incoming📉☠️🖕.
$GNS down 50% from RS. shitco CEOs. Shitco companies. Laughing at retail investors. Fuck these companies. Fuck Malone for utilizing his
$GME pull to reel in lemmings to these shitcos.
$FNGR $NWBO
0 replies
FickleFin
Nov 20, 7:05 AM
$QNTM shitco CEO selling shares 📉☠️
$GNS shitco CEO RS done. Short it.📉☠️ Another RS in the horizon. 🤡🥴
$FNGR $NWBO
0 replies
FickleFin
Nov 19, 1:38 PM
$QNTM $GNS I can promise you 100% Its all a grift. 📉... ☠️
1 replies
FickleFin
Nov 18, 6:07 PM
$QNTM $GNS
they're selling on you... big red candles. 🤡
0 replies